- Home
- SBET vs SCNI Comparison
SBET vs SCNI Comparison
Compare SBET & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- SCNI
- Stock Information
- Founded
- SBET 1995
- SCNI 2003
- Country
- SBET United States
- SCNI Israel
- Employees
- SBET N/A
- SCNI N/A
- Industry
- SBET Computer Software: Prepackaged Software
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBET Technology
- SCNI Health Care
- Exchange
- SBET Nasdaq
- SCNI Nasdaq
- Market Cap
- SBET 1.8M
- SCNI 1.9M
- IPO Year
- SBET 1997
- SCNI N/A
- Fundamental
- Price
- SBET $0.27
- SCNI $2.55
- Analyst Decision
- SBET
- SCNI
- Analyst Count
- SBET 0
- SCNI 0
- Target Price
- SBET N/A
- SCNI N/A
- AVG Volume (30 Days)
- SBET 1.7M
- SCNI 18.0K
- Earning Date
- SBET 05-16-2025
- SCNI 05-14-2025
- Dividend Yield
- SBET N/A
- SCNI N/A
- EPS Growth
- SBET N/A
- SCNI N/A
- EPS
- SBET 2.93
- SCNI 8.20
- Revenue
- SBET $3,662,349.00
- SCNI $452,000.00
- Revenue This Year
- SBET N/A
- SCNI N/A
- Revenue Next Year
- SBET N/A
- SCNI N/A
- P/E Ratio
- SBET $0.16
- SCNI $0.30
- Revenue Growth
- SBET N/A
- SCNI N/A
- 52 Week Low
- SBET $0.19
- SCNI $1.90
- 52 Week High
- SBET $1.31
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- SBET 49.14
- SCNI 45.49
- Support Level
- SBET $0.19
- SCNI $1.90
- Resistance Level
- SBET $0.24
- SCNI $2.54
- Average True Range (ATR)
- SBET 0.04
- SCNI 0.29
- MACD
- SBET 0.01
- SCNI 0.04
- Stochastic Oscillator
- SBET 55.17
- SCNI 47.71
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.